Egypt Strengthens African Cooperation to Localize Vaccine Manufacturing and Health Security
Cairo witnessed the launch of the fifth edition of the Africa Health ExCon 2026, a prominent event aimed at developing the health sector on the African continent. Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Drug Authority, participated in this significant event to foster cooperation among African nations in the field of healthcare.
Discussions during the conference focused on the importance of localizing vaccine manufacturing within African countries. This step aims to reduce reliance on imports from abroad and ensure the availability of essential medicines and vaccines for citizens across the continent in a faster and more sustainable manner.
In this context, Dr. Al-Ghamrawi witnessed the signing ceremony of a series of new strategic partnerships. These agreements include the transfer of modern medical technology to Egypt and other African nations, which helps in developing the infrastructure of pharmaceutical industries and increasing the efficiency of local production to meet market needs.
These efforts come within the framework of Egypt's vision to enhance regional health security, as the country seeks to become a regional hub for vaccine manufacturing. These partnerships represent a practical step toward achieving health self-sufficiency and ensuring the ability of African nations to collectively and systematically face future health challenges.